[Treatment of histamine-dependent allergic dermatoses with a 120-mg terfenadine tablet once a day].
Terfenadine, an anti-H1-selective antihistaminic drug has been used in an experimental clinical study. The effectiveness and tolerance of the compound in the treatment of pruritic dermatitis such as urticaria, atopic dermatitis and topical dermatitis, have been evaluated. Terfenadine, administered in 120 mg tablets in a single daily dose in 30 patients demonstrated a fully satisfactory therapeutic activity and reliability of use.
Rigoni
C
C
Cantù
A
A
Toffolo
P
P
Romagnoni
G
G
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001559:Benzhydryl Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D003872:Dermatitis / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013607:Tablets; D016593:Terfenadine
D001559:Benzhydryl Compounds; D006634:Histamine H1 Antagonists; D013607:Tablets; D016593:Terfenadine
Trattamento delle dermatosi allergiche istamino-dipendenti con terfenadina compresse 120 mg in monosomministrazione giornaliera.